Today on Outsourcing-Pharma.com   Sanofi slammed by FDA over failure to act on Ketek fraud GSK cut down by Avandia scare MannKind all but shuts the door on Pfizer Almac to take on US with $100m Sigma-Aldrich set to break $2bn yearly sales barrier

Related Industry News   Pharmaceutical patent round-up Merck KGaA pulls out of diabetes research Personalised medicine leaves public cold WHO flu vaccine forecast an underestimate

Breaking News on Outsourcing Pharma
Daily  Thursday 25 October 2007		Forward to a colleague

	Product Brochure Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here Access Full Stories Sanofi slammed by FDA over failure to act on Ketek fraud The US Food and Drug Administration (FDA) has slammed Sanofi-Aventis over its failure to act on known instances of fraud during clinical trials of its antibiotic Ketek (telithromycin) - accusations that the firm... Read GSK cut down by Avandia scare GlaxoSmithKline (GSK) has emerged as the latest pharma firm to announce closures and job cuts along with its third quarter results, yet another casualty of generic competition and product safety scares... Read MannKind all but shuts the door on Pfizer MannKind Corporation needs an outside boost to get its inhaled insulin off the ground, but the likelihood of that partner being Pfizer is a 'very long shot', the president of the company says... Read Almac to take on US with $100m Contract manufacturer Almac has set its sights on establishing a new US headquarters and has set aside $100m (€70m) for the purpose... Read Sigma-Aldrich set to break $2bn yearly sales barrier Sigma-Aldrich continued its strong year with both revenues and pre-tax profits showing strong double-digit growth in the third quarter predicting it will break the $2bn (€1.4bn) revenue mark this year... Read
	All News Headlines for: October | September | August
	Related Industry News Pharmaceutical patent round-up In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations... Read Merck KGaA pulls out of diabetes research In a shock announcement at its third quarter financial results, Merck KGaA has said it will stop its diabetes research and partner out any current programmes... Read Personalised medicine leaves public cold For some people, the promise of personalised medicine just means more worry and potential stigmatisation and they'd simply rather not know if they are genetically susceptible to a certain disease, such as cancer... Read WHO flu vaccine forecast an underestimate The forecast that 4.5 billion doses of pandemic influenza vaccine could be produced by 2010 is an underestimate, according to GlaxoSmithKline... Read Weekly Comment 'We are not anti-Asia' says EU chemicals body There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers. Read Previous Headlines eClinical news in brief Outsourcing-Pharma tracks the latest eClinical movements, featuring Medidata, Clinphone, Phlexglobal and Octagon Research Solutions... Read Pfizer's cost-cutting focus no 'Kindler surprise' As it faces an increasingly uncertain financial future, Pfizer's reaffirmation that it plans to retain its focus on cutting costs, including outsourcing and offshoring, comes as no 'Kindler surprise', unlike the... Read J&J, Galapagos sign deal to search for arthritis 'Holy Grail' Belgian biotech Galapagos has penned 'by far' its biggest ever deal, with Johnson & Johnson (J&J) committing an estimated €1bn to a joint arthritis research programme... Read Global pact to fight fakes A major new trade agreement aiming to combat counterfeiting has been proposed by representatives of a number of key markets, including the US, EU and several other countries worldwide... Read Pfizer not alone in feeling the heat of California fires As the fires in California continue to rage, Pfizer and other pharma and biotech companies all over Southern California are bracing themselves for closures and even evacuations of their facilities... Read Product Information - brochures, Web centers Benefits of integrating human tissue research in drug discovery - Company Profile Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com